Close Menu

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Thursday that its fourth-quarter revenues increased 15 percent year over year as the firm missed consensus Wall Street estimates on the top line but easily beat it on the bottom line.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.